Literature DB >> 8627772

The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.

M S McBride1, A T Panganiban.   

Abstract

We analyzed the leader region of human immunodeficiency virus type 1 (HIV-1) RNA to decipher the nature of the cis-acting E/psi element required for encapsidation of viral RNA into virus particles. Our data indicate that, for RNA encapsidation, there are at least two functional subregions in the leader region. One subregion is located at a position immediately proximal to the major splice donor, and the second is located between the splice donor and the beginning of the gag gene. This suggests that at least two discrete cis-acting elements are recognition signals for encapsidation. To determine whether specific putative RNA secondary structures serve as the signal(s) for encapsidation, we constructed primary base substitution mutations that would be expected to destabilize these potential structures and second-site compensatory mutations that would restore secondary structure. Analysis of these mutants allowed the identification of two discrete hairpins that facilitate RNA encapsidation in vivo. Thus, the HIV-1 E/psi region is a multipartite element composed of specific and functional RNA secondary structures. Compensation of the primary mutations by the second-site mutations could not be attained in trans. This indicates that interstrand base pairing between these two stem regions within the hairpins does not appear to be the basis for HIV-1 RNA dimer formation. Comparison of the hypothetical RNA secondary structures from 10 replication-competent HIV-1 strains suggests that a subset of the hydrogen-bonded base pairs within the stems of the hairpins is likely to be required for function in cis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627772      PMCID: PMC190155     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  58 in total

1.  Avian retroviral RNA encapsidation: reexamination of functional 5' RNA sequences and the role of nucleocapsid Cys-His motifs.

Authors:  R Aronoff; A M Hajjar; M L Linial
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

2.  Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  K Sakaguchi; N Zambrano; E T Baldwin; B A Shapiro; J W Erickson; J G Omichinski; G M Clore; A M Gronenborn; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

3.  Characterization of a Rous sarcoma virus mutant defective in packaging its own genomic RNA: biochemical properties of mutant TK15 and mutant-induced transformants.

Authors:  T Koyama; F Harada; S Kawai
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

4.  Analytical study of avian reticuloendotheliosis virus dimeric RNA generated in vivo and in vitro.

Authors:  J L Darlix; C Gabus; B Allain
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Maturation of dimeric viral RNA of Moloney murine leukemia virus.

Authors:  W Fu; A Rein
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

6.  Simian immunodeficiency virus RNA is efficiently encapsidated by human immunodeficiency virus type 1 particles.

Authors:  T A Rizvi; A T Panganiban
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA.

Authors:  W I Sundquist; S Heaphy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses.

Authors:  I Katoh; T Yasunaga; Y Yoshinaka
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

9.  Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.

Authors:  F Baudin; R Marquet; C Isel; J L Darlix; B Ehresmann; C Ehresmann
Journal:  J Mol Biol       Date:  1993-01-20       Impact factor: 5.469

10.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  143 in total

1.  A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.

Authors:  N Srinivasakumar; F G Schuening
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium binding.

Authors:  F Jossinet; J C Paillart; E Westhof; T Hermann; E Skripkin; J S Lodmell; C Ehresmann; B Ehresmann; R Marquet
Journal:  RNA       Date:  1999-09       Impact factor: 4.942

3.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

5.  The leader of the HIV-1 RNA genome forms a compactly folded tertiary structure.

Authors:  B Berkhout; J L van Wamel
Journal:  RNA       Date:  2000-02       Impact factor: 4.942

6.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Two alternating structures of the HIV-1 leader RNA.

Authors:  H Huthoff; B Berkhout
Journal:  RNA       Date:  2001-01       Impact factor: 4.942

8.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

10.  Elements located upstream and downstream of the major splice donor site influence the ability of HIV-2 leader RNA to dimerize in vitro.

Authors:  Jean-Marc Lanchy; Casey A Rentz; John D Ivanovitch; J Stephen Lodmell
Journal:  Biochemistry       Date:  2003-03-11       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.